Edition:
United Kingdom

Bioverativ Inc (BIVV.OQ)

BIVV.OQ on NASDAQ Stock Exchange Global Select Market

53.49USD
12 Dec 2017
Change (% chg)

$0.63 (+1.19%)
Prev Close
$52.86
Open
$53.08
Day's High
$53.75
Day's Low
$52.39
Volume
417,145
Avg. Vol
368,967
52-wk High
$64.40
52-wk Low
$41.21

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Brian Posner

55 2017 Independent Chairman of the Board

John Cox

54 2016 Chief Executive Officer, Director

John Greene

51 2016 Chief Financial Officer, Executive Vice President, Treasurer

Rogerio Vivaldi Coelho

53 2016 Executive Vice President, Chief Global Therapeutic Operations Officer

Lucia Celona

51 2017 Executive Vice President, Chief Human Resources and Corporate Communications Officer